In line with the literature described above, our preliminary experimental results also support the notion that GFLs or compounds targeting GDNF receptor RET (Bespalov et al., 2016; Sidorova et al., 2017; Viisanen et al., 2020) can reduce the expression of satellite glia marker in sensory ganglia of animals with surgery or diabetes-induced neuropathy. Here, RET is linked to neuropathy.